1. AB0282 Adjusting the dose of tofacitinib to achieve optimal results in the management of patients with active rheumatoid arthritis (RA) may offer more successful results than utilising a standard fixed one dose approach. (12th June 2018) Authors: Gaylis, N.; Sagliani, J.; Needell, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0503 The Effect of Corticotropin (ACTH 80 Units Weekly or Biweekly) in Combination with MTX in Newly Diagnosed RA Patients from a Clinical and Structural Perspective as Measured by a CDAI Score and Osteitis, Synovitis, and Erosions on MRI. (9th June 2015) Authors: Gaylis, N.; Needell, S.; Sagliani, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1036 Updated Results from The Pro Assessment of Inflammatory Arthritis Patients' Experience with IV Administered Biologic Therapy. (15th July 2016) Authors: Gaylis, N.; Sagliani, J.; Black, S.; Tang, K.; Dehoratius, R.; Parenti, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0495 Magnetic resonance imaging may be helpful in predicting long term efficacy of certolizumab pegol in patients with active rheumatoid arthritis. (23rd January 2014) Authors: Olech, E.; Peterfy, C.; DiCarlo, J.; Sagliani, J.; Genovese, A.; Gaylis, N. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0595 Responsiveness and Test-Retest Reliability of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation To SLEDAI-2K. (15th July 2016) Authors: Chatham, W.W.; Collins, C.E.; Gaylis, N.; Busch, H.; Hautamaki, E.; Narayanan, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0202 Five-Year Safety and Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Despite Previous Anti-Tumor Necrosis Factor Therapy: Final Study Results of the Phase 3, Randomized, Placebo-Controlled Go-After Trial. (23rd January 2014) Authors: Smolen, J. S.; Kay, J.; Landewé, R.; Matteson, E. L.; Gaylis, N.; Wollenhaupt, J.; Murphy, F. T.; Han, C.; Gathany, T.; Xu, S.; Zhou, Y.; Hsia, E. C.; Doyle, M. K. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗